Literature DB >> 30039520

The mRNA-binding protein Serbp1 as an auxiliary protein associated with mammalian cytoplasmic ribosomes.

Akiko Muto1, Yoshihiko Sugihara1, Minami Shibakawa1, Kenzi Oshima1, Tsukasa Matsuda1, Daita Nadano1.   

Abstract

While transcription plays an obviously important role in gene expression, translation has recently been emerged as a key step that defines the composition and quality of the proteome in the cell of higher eukaryotes including mammals. Selective translation is supposed to be regulated by the structural heterogeneity of cytoplasmic ribosomes including differences in protein composition and chemical modifications. However, the current knowledge on the heterogeneity of mammalian ribosomes is limited. Here, we report mammalian Serbp1 as a ribosome-associated protein. The translated products of Serbp1 gene, including the longest isoform, were found to be localized in the nucleolus as well as in the cytoplasm. Subcellular fractionation indicated that most of cytoplasmic Serbp1 molecules were precipitated by ultracentrifugation. Proteomic analysis identified Serbp1 in the cytoplasmic ribosomes of the rodent testis. Polysome profiling suggested that Serbp1, as a component of the small 40S subunit, was included in translating ribosomes (polysomes). Cosedimentation of Serbp1 with the 40S subunit was observed after dissociation of the ribosomal subunits. Serbp1 was also included in the ribosomes of human cancer cells, which may lead to a mechanistic understanding of an emerging link between Serbp1 and tumour progression. SIGNIFICANCE OF THE STUDY: In mammalian cells, the final protein output of their genetic program is determined not only by controlling transcription but also by regulating the posttranscriptional events. Although mRNA-binding proteins and the cytoplasmic ribosome have long been recognized as central players in the posttranscriptional regulation, their physical and functional interactions are still far from a complete understanding. Here, we describe the intracellular localization of Serbp1, an mRNA-binding protein, and the inclusion of this protein in actively translating ribosomes in normal and cancer cells. These findings shed a new light into molecular mechanisms underlying Serbp1 action in translational gene regulation and tumour progression.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cytoplasmic ribosome; gene expression; isoform; mRNA-binding protein; malignant tumour; mammal; polysome; translational control

Mesh:

Substances:

Year:  2018        PMID: 30039520     DOI: 10.1002/cbf.3350

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  13 in total

Review 1.  The space between notes: emerging roles for translationally silent ribosomes.

Authors:  Patrick R Smith; Sapna C Pandit; Sarah Loerch; Zachary T Campbell
Journal:  Trends Biochem Sci       Date:  2022-03-01       Impact factor: 14.264

Review 2.  Does functional specialization of ribosomes really exist?

Authors:  Max B Ferretti; Katrin Karbstein
Journal:  RNA       Date:  2019-02-07       Impact factor: 4.942

3.  An ortholog of the Vasa intronic gene is required for small RNA-mediated translation repression in Chlamydomonas reinhardtii.

Authors:  Xinrong Ma; Fadia Ibrahim; Eun-Jeong Kim; Scott Shaver; James Becker; Fareha Razvi; Ronald L Cerny; Heriberto Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

4.  The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction.

Authors:  Ewan M Smith; Nour El Houda Benbahouche; Katherine Morris; Ania Wilczynska; Sarah Gillen; Tobias Schmidt; Hedda A Meijer; Rebekah Jukes-Jones; Kelvin Cain; Carolyn Jones; Mark Stoneley; Joseph A Waldron; Cameron Bell; Bruno D Fonseca; Sarah Blagden; Anne E Willis; Martin Bushell
Journal:  Nucleic Acids Res       Date:  2021-01-11       Impact factor: 16.971

5.  Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance.

Authors:  Patrick R Smith; Sarah Loerch; Nikesh Kunder; Alexander D Stanowick; Tzu-Fang Lou; Zachary T Campbell
Journal:  Nat Commun       Date:  2021-11-23       Impact factor: 14.919

6.  A genetically-encoded crosslinker screen identifies SERBP1 as a PKCε substrate influencing translation and cell division.

Authors:  Silvia Martini; Khalil Davis; Rupert Faraway; Lisa Elze; Nicola Lockwood; Andrew Jones; Xiao Xie; Neil Q McDonald; David J Mann; Alan Armstrong; Jernej Ule; Peter J Parker
Journal:  Nat Commun       Date:  2021-11-26       Impact factor: 14.919

7.  The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.

Authors:  Adam Kosti; Patricia Rosa de Araujo; Wei-Qing Li; Gabriela D A Guardia; Jennifer Chiou; Caihong Yi; Debashish Ray; Fabiana Meliso; Yi-Ming Li; Talia Delambre; Mei Qiao; Suzanne S Burns; Franziska K Lorbeer; Fanny Georgi; Markus Flosbach; Sarah Klinnert; Anne Jenseit; Xiufen Lei; Carolina Romero Sandoval; Kevin Ha; Hong Zheng; Renu Pandey; Aleksandra Gruslova; Yogesh K Gupta; Andrew Brenner; Erzsebet Kokovay; Timothy R Hughes; Quaid D Morris; Pedro A F Galante; Stefano Tiziani; Luiz O F Penalva
Journal:  Genome Biol       Date:  2020-08-06       Impact factor: 13.583

8.  ALC1/eIF4A1-mediated regulation of CtIP mRNA stability controls DNA end resection.

Authors:  Fernando Mejías-Navarro; Guillermo Rodríguez-Real; Javier Ramón; Rosa Camarillo; Pablo Huertas
Journal:  PLoS Genet       Date:  2020-05-11       Impact factor: 5.917

9.  Actinin BioID reveals sarcomere crosstalk with oxidative metabolism through interactions with IGF2BP2.

Authors:  Feria A Ladha; Ketan Thakar; Anthony M Pettinato; Nicholas Legere; Shahnaz Ghahremani; Rachel Cohn; Robert Romano; Emily Meredith; Yu-Sheng Chen; J Travis Hinson
Journal:  Cell Rep       Date:  2021-08-10       Impact factor: 9.423

10.  ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.

Authors:  Kristian Lied Wollen; Lars Hagen; Cathrine B Vågbø; Renana Rabe; Tobias S Iveland; Per Arne Aas; Animesh Sharma; Bjørnar Sporsheim; Hilde O Erlandsen; Vuk Palibrk; Magnar Bjørås; Davi M Fonseca; Nima Mosammaparast; Geir Slupphaug
Journal:  J Transl Med       Date:  2021-07-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.